Bowhead Specialty (NYSE:BOW) Upgraded to Strong-Buy at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods upgraded shares of Bowhead Specialty (NYSE:BOW) from a moderate buy rating to a strong-buy rating in a report issued on Monday morning,Zacks.com reports.

BOW has been the topic of several other reports. Piper Sandler upped their price objective on shares of Bowhead Specialty from $30.00 to $32.00 and gave the stock an “overweight” rating in a research note on Monday, December 22nd. Zacks Research upgraded shares of Bowhead Specialty from a “strong sell” rating to a “hold” rating in a research note on Tuesday, February 24th. Morgan Stanley reduced their target price on Bowhead Specialty from $31.00 to $29.00 and set an “equal weight” rating on the stock in a report on Monday, November 17th. Royal Bank Of Canada dropped their price target on Bowhead Specialty from $33.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, February 25th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Bowhead Specialty in a research report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $33.33.

Bowhead Specialty Stock Up 0.7%

Shares of NYSE BOW opened at $22.71 on Monday. Bowhead Specialty has a 52-week low of $21.93 and a 52-week high of $42.29. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.52 and a current ratio of 0.52. The business has a fifty day moving average of $24.52 and a two-hundred day moving average of $26.23. The stock has a market cap of $744.40 million, a PE ratio of 14.28, a PEG ratio of 0.68 and a beta of -1.06.

Bowhead Specialty (NYSE:BOW) last posted its earnings results on Tuesday, February 24th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.02. The business had revenue of $151.68 million for the quarter, compared to analyst estimates of $145.99 million. Bowhead Specialty had a net margin of 9.75% and a return on equity of 13.27%. As a group, equities research analysts expect that Bowhead Specialty will post 1.36 earnings per share for the current fiscal year.

Institutional Trading of Bowhead Specialty

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BOW. Y Intercept Hong Kong Ltd lifted its stake in shares of Bowhead Specialty by 47.3% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 133,958 shares of the company’s stock valued at $3,622,000 after purchasing an additional 43,029 shares during the period. DAVENPORT & Co LLC grew its stake in shares of Bowhead Specialty by 205.7% during the third quarter. DAVENPORT & Co LLC now owns 269,769 shares of the company’s stock worth $7,295,000 after purchasing an additional 181,531 shares during the period. American Century Companies Inc. increased its holdings in Bowhead Specialty by 1.6% in the second quarter. American Century Companies Inc. now owns 815,217 shares of the company’s stock valued at $30,595,000 after purchasing an additional 12,849 shares during the last quarter. Victory Capital Management Inc. lifted its stake in Bowhead Specialty by 54.3% in the third quarter. Victory Capital Management Inc. now owns 1,525,285 shares of the company’s stock valued at $41,244,000 after buying an additional 536,817 shares during the period. Finally, Cynosure Group LLC acquired a new position in Bowhead Specialty in the second quarter valued at about $728,000.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.